There are many forms of treatment recommended but in general they fall into 3 categories:
- Medical therapy
- Ablative therapy
- Microvascular decompression
Medical Therapy:
Drugs similar to that for trigeminal Neuralgia have been tried for glossopharyngeal neuralgia with little success. These medications are intended to calm or improve the function of the nerve. In general these are medications often used for seizures of the brain (Tegretol, Dilantin and Lamictal). Unfortunately these rarely provide consistent relief and may create unwanted side-effects, such as, sedation, lethargy, cognitive impairment amongst others. Under these circumstances patients may wish to consider other therapies.
Ablative Therapy:
These therapies are designed to ablate or selectively destroy specific fibres of the glossopharyngeal nerve. The procedure consists of a variety of approaches of cutting or sectioning the nerve. In our experience these are unsuccessful and may close the door for subsequent definitive therapy.
Microvascular Decompression:
This procedure is intended to move the offending vessel and create a cushion or pad between the glossopharyngeal nerve and the upper two branches (fassicles) of the vagus nerve and the offending vessel(s). The decompression addresses the root cause of glossopharyngeal neuralgia by dealing with vessel that is causing the compression. The approach involves a minimally invasive keyhole retromastoid approach. This approach involves making a small incision behind the ear and a key whole opening in the bone. Using the natural space that is created when the cerebrospinal fluid is drained direct access to the glossopharyngeal and vagus nerve and offending vessel is provided. Using this space there is little need for manipulation of the brain and nerves. Small pads of Teflon are placed between the nerve and vessel. Occasionally also treating the Nervus Intermedius may improve the outcome.